ITUA20161673A1 - USE OF A PHARMACEUTICAL FORMULATION IN HUMAN VETERINARY AND HEALTHCARE MEDICAL AREA. THE FORMULATION PROVIDES THE USE OF DIBASIC HYPOCHLORITE OF MAGNESIUM IN ACID ENVIRONMENT - Google Patents

USE OF A PHARMACEUTICAL FORMULATION IN HUMAN VETERINARY AND HEALTHCARE MEDICAL AREA. THE FORMULATION PROVIDES THE USE OF DIBASIC HYPOCHLORITE OF MAGNESIUM IN ACID ENVIRONMENT

Info

Publication number
ITUA20161673A1
ITUA20161673A1 ITUA2016A001673A ITUA20161673A ITUA20161673A1 IT UA20161673 A1 ITUA20161673 A1 IT UA20161673A1 IT UA2016A001673 A ITUA2016A001673 A IT UA2016A001673A IT UA20161673 A ITUA20161673 A IT UA20161673A IT UA20161673 A1 ITUA20161673 A1 IT UA20161673A1
Authority
IT
Italy
Prior art keywords
magnesium
formulation
acid environment
medical area
pharmaceutical formulation
Prior art date
Application number
ITUA2016A001673A
Other languages
Italian (it)
Inventor
Danilo Coral
Damiano Luzietti
Paolo Ruffini
Eloisa Terzo
Original Assignee
Danilo Coral
Damiano Luzietti
Paolo Ruffini
Eloisa Terzo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danilo Coral, Damiano Luzietti, Paolo Ruffini, Eloisa Terzo filed Critical Danilo Coral
Priority to ITUA2016A001673A priority Critical patent/ITUA20161673A1/en
Publication of ITUA20161673A1 publication Critical patent/ITUA20161673A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
ITUA2016A001673A 2016-03-15 2016-03-15 USE OF A PHARMACEUTICAL FORMULATION IN HUMAN VETERINARY AND HEALTHCARE MEDICAL AREA. THE FORMULATION PROVIDES THE USE OF DIBASIC HYPOCHLORITE OF MAGNESIUM IN ACID ENVIRONMENT ITUA20161673A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITUA2016A001673A ITUA20161673A1 (en) 2016-03-15 2016-03-15 USE OF A PHARMACEUTICAL FORMULATION IN HUMAN VETERINARY AND HEALTHCARE MEDICAL AREA. THE FORMULATION PROVIDES THE USE OF DIBASIC HYPOCHLORITE OF MAGNESIUM IN ACID ENVIRONMENT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUA2016A001673A ITUA20161673A1 (en) 2016-03-15 2016-03-15 USE OF A PHARMACEUTICAL FORMULATION IN HUMAN VETERINARY AND HEALTHCARE MEDICAL AREA. THE FORMULATION PROVIDES THE USE OF DIBASIC HYPOCHLORITE OF MAGNESIUM IN ACID ENVIRONMENT

Publications (1)

Publication Number Publication Date
ITUA20161673A1 true ITUA20161673A1 (en) 2017-09-15

Family

ID=56551442

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUA2016A001673A ITUA20161673A1 (en) 2016-03-15 2016-03-15 USE OF A PHARMACEUTICAL FORMULATION IN HUMAN VETERINARY AND HEALTHCARE MEDICAL AREA. THE FORMULATION PROVIDES THE USE OF DIBASIC HYPOCHLORITE OF MAGNESIUM IN ACID ENVIRONMENT

Country Status (1)

Country Link
IT (1) ITUA20161673A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123377A (en) * 1977-08-25 1978-10-31 The Procter & Gamble Company Particulate detergent composition containing dibasic magnesium hypochlorite
US4236891A (en) * 1979-02-05 1980-12-02 Olin Corporation Process for textile bleaching with dibasic magnesium hypochlorite
WO2013134327A1 (en) * 2012-03-06 2013-09-12 Raymat Materials, Inc. Disinfectant solution
US20140328946A1 (en) * 2007-03-13 2014-11-06 Oculus Innovative Sciences, Inc. Antimicrobial solutions containing dichloride monoxide and methods of making and using the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123377A (en) * 1977-08-25 1978-10-31 The Procter & Gamble Company Particulate detergent composition containing dibasic magnesium hypochlorite
US4236891A (en) * 1979-02-05 1980-12-02 Olin Corporation Process for textile bleaching with dibasic magnesium hypochlorite
US20140328946A1 (en) * 2007-03-13 2014-11-06 Oculus Innovative Sciences, Inc. Antimicrobial solutions containing dichloride monoxide and methods of making and using the same
WO2013134327A1 (en) * 2012-03-06 2013-09-12 Raymat Materials, Inc. Disinfectant solution

Similar Documents

Publication Publication Date Title
IL275704A (en) Oral pharmaceutical formulation comprising cannabinoids and poloxamer
BR112018076601A2 (en) oral pharmaceutical formulation, methods for treating a patient, and use of a formulation
DK3709978T3 (en) Pharmaceutical oral formulation comprising bacteria
CY1123366T1 (en) 8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
MY191980A (en) Formulations containing an extract of echinacea and linoleic acid derivatives
CR20150266A (en) MODIFIED RELEASE FORMULATIONS FOR OPROZOMIB
EP3552612A4 (en) PHARMACEUTICAL COMPOSITION AND MEDICAL INSTRUMENT
ECSP16086247A (en) (S) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
HUE052837T2 (en) Pharmaceutical preparations for lysosome storage disease and their applications
MX379253B (en) STABILIZED OXYMETAZOLINE FORMULATIONS AND THEIR USES.
EP3773654A4 (en) PHARMACEUTICAL COMPOSITIONS OF THE ACTIVE SUBSTANCE AND RELATED PROCEDURES
EP4013418A4 (en) DERMAL PHARMACEUTICAL URACIL FORMULATION
MA44286A (en) PHARMACEUTICAL FORMULATION OF CINEOL AND AMOXICILLIN
IL251555A0 (en) Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases
ECSP16086232A (en) (R) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
EP3813799C0 (en) PHARMACEUTICAL FORMULATION WITH IMPROVED SOLUBILITY AND BIOAVAILABILITY
CL2012003209A1 (en) Synthesis method of poly (lactic-glycolic acid) nanoparticles (plga) with pentoxifylline; pharmaceutical composition comprising nanoparticles of pest with pentoxifylline; and use of the nanoparticles loaded with pentoxifylline in the treatment of relief and prevention of chronic pain.
IT201700124249U1 (en) PORTABLE EQUIPMENT FOR THE ADMINISTRATION OF A GAS MIX IN CARDIOPULMONAR RESUSCITATION OF A PATIENT
ITUA20161673A1 (en) USE OF A PHARMACEUTICAL FORMULATION IN HUMAN VETERINARY AND HEALTHCARE MEDICAL AREA. THE FORMULATION PROVIDES THE USE OF DIBASIC HYPOCHLORITE OF MAGNESIUM IN ACID ENVIRONMENT
Carberry How helpful are early warning scores?
EP3520733A4 (en) ANTI-STRUCTURE STRUCTURE USED IN THE HANDLE OF AN ULTRASONIC DENTAL DETECTOR
GB201410869D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
UY37413A (en) OPROZOMIB IMMEDIATE RELEASE FORMULATIONS
EP3474840A4 (en) USE OF CYANOGLUCOSIDES AND PHARMACEUTICAL FORMULATIONS THEREOF IN THE TREATMENT OF DIABETES
EP3463296A4 (en) PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF